throbber
International Journal of Pharmaceutics, 41 (1988) 105-113
`Elsevier
`
`UP 01378
`
`Light degradation of ketorolac tromethamine
`
`Leo Gu, Hi-Shi Chiang and David Johnson
`Institute of Pharmaceutical Sciences, Syntex Research, Palo Alto, CA 94304 (U.S.A.)
`
`(Received 2 December 1986)
`(Accepted 20 July 1987)
`
`Key words: Ketorolac tromethamine; Stability; Autoxidation; Light degradation; Mechanism
`
`Summary
`
`Aqueous and ethanol solutions of ketorolac tromethamine were found to decompose rapidly under laboratory black light (350
`nm) to yield CO2, decarboxylation product 4 and 3 oxidation products, 1, 2, and 3. Complete material balance of these 4 products in
`ethanol was found while the material balance in aqueous solutions was poor and decreased with the extent of the reaction. A
`mechanism which involves an initial decarboxylation of the triplet excited state of ketorolac, followed by oxidation. is proposed to
`account for the observed oxygen concentration-dependent kinetics and the product distribution of the reaction.
`
`Introduction
`
`Drug substances stored either as pure raw
`material, in the solid or liquid dosage forms, or
`during the manufacturing processes, are subject to
`various degrees of irradiation by sunlight and
`fluorescent
`room light. Drugs with absorption
`greater than 280 nm have the potential for decom-
`position in sunlight and drugs with absorption
`maxima greater than 400 nm have the potential
`for degradation in both sunlight and room light.
`Direct sunlight and room light experiments are
`time-consurning and often result
`in inconsistent
`data due to the day-to-day variation in the light
`intensity. Different light model systems have been
`used to simulate the light degradation of drug
`substances (Lachman et al., 1960; Lin and Lach-
`man, 1969; Griinert and Wollman, 1978). One of
`
`Correspondence: L. Gu, Institute of Pharmaceutical Sciences,
`Syntex Research, Palo Alto, CA 94304, U.S.A.
`
`these consists of a Rayonet Photochemical Reac-
`tor equipped with laboratory black lights (350
`nm). This system accelerates the degradation by
`~ 150 times compared to typical north window
`sunlight and by 2 75,000 times compared to typi-
`cal laboratory fluorescent light. It has been used
`successfully in evaluating the light reactivities of a
`series of compounds with different functionalities
`in this laboratory. This paper reports the light
`stability studies of ketorolac trometharnine,
`a
`potent non-narcotic analgesic agent (Muchowski
`et al., 1985; Bloomfield et al., 1984; Yee et al.,
`1984, 1985), in various aqueous and ethanol solu-
`tions in a Rayonet Photochemical Reactor (see
`Scheme 1).
`
`Materials and Methods
`
`Materials
`Ketorolac tromethamine was obtained from the
`
`Institute of Organic Chemistry, Syntex Research.
`
`0378-5173/88/$03.50 © 1988 Elsevier Science Publishers BV. (Biomedical Division)
`
`IPR2015-01099
`IPR2015-01097
`IPR2015-01100
`IPR2015-01105
`
`Lupin EX1171
`Page 1
`
`

`
`106
`
`Ethanol was USP grade and buffers were reagent
`grade. High-performance liquid chromatography
`(HPLC) grade acetonitrile and nanopure water
`were used to prepare the mobile phase.
`
`Kinetics
`
`Photolysis of ketorolac tromethamine was per-
`formed in a Rayonet model RPR 1000 Photo-
`chemical Reactor equipped with sixteen 350—nm
`black-light
`lamps. Sample solutions of ketorolac
`tromethamine in various media were prepared and
`transferred into a set of clear pyrex culture tubes
`(i.d. = 15 i 1 mm) before photolysis. For irradia-
`tion under oxygen or argon, sample solutions in
`culture tubes were purged with solvent-saturated
`gas for at least 10 min before sealing with Teflon-
`lined caps. A stability-specific HPLC method (see
`below) was used to follow the extent of the reac-
`tion.
`
`Preparation of degradation products I -4
`A stock solution containing 100 mg ketorolac
`tromethamine in EtOH/H20 (1/9, v/v) was pre-
`pared and transferred into eight 20 ml culture
`tubes. The solutions were purged with oxygen for
`5 min, sealed with Teflon-lined caps and irradia-
`ted with 350 nm lamps in a Rayonet Photochem-
`ical Reactor at 0°C (maintained using an ice
`bath) to ~ 80% completion. The reaction mixtures
`were combined, evaporated to dryness. and stored
`in a freezer before analysis. Samples were then
`dissolved in mobile phase and separated by semi-
`preparative HPLC (see HPLC methods below) to
`give ~ 4-6 mg of each of the degradation prod-
`ucts 1-4.
`
`Compound 1 was identified to be (:)-5-ben-
`zoyl-2,3-dihydro-1-hydroxy-3H-pyrrolo[1,2a]pyr—
`role:
`‘H NMR (300 MHz, CDCI3) 8 2.53-2.91
`(2H, m. C—CH2—C), 4.52 (2H, m, N-CH2), 5.27
`(1H, dd, -CH-OH), 6.18-6.85 (2H, dd, pyrrolic),
`7.47-7.83 (5H, m, Ph); EIMS (70 eV. m/e) 227
`(m/b).
`210.
`105,
`77; HRMS, Calcd.
`for
`CMHBNO2: 227.0946. Found: 227.0946. Anal.
`Calcd.: C, 73.99; H, 5.77; N, 6.16. Found: C,
`73.71; H, 5.82; N, 6.45.
`Compound 2 was identified to be (i)—5-ben-
`zoyl-2,3-dihydro-1-hydroperoxy-3H-pyrrolo[1,2a]-
`pyrrole: 1H NMR (300 MHZ, CDCI3) oz 2.73-2.85
`
`(2H, m, C-CH2—C), 4.52 (2H, m, N-CH3). 5.47
`(1H, dd, —CH—OOH), 6.27-6.99 (2H, dd, pyr-
`rolic), 7.47-7.83 (5H, m, Ph). 7.95 (1H, bs, -OOH);
`EIMS (80 eV. m/e) 243(m), 227, 210, 105(b), 77.
`Anal. Calcd. for CMHUNO3: C, 69.12; H, 5.39;
`N, 5.76. Found: C, 68.92; H, 5.17; N. 5.91.
`Compound 3 was identified to be 5-benzoy1-
`2,3-dihydro-1-oxopyrrolo[1.2a]pyrrole. The
`‘H
`NMR, MS and CHN analysis data have been
`reported elsewhere (Gu et al., 1987).
`Compound 4 was identified to be 5—benzoyl-
`1,2-dihydro-3H-pyrrolo[1,2a]pyrrole:
`‘H NMR
`(300 MHz. CDCI3) 8 2.57 (2H. p. -C-CH3-C).
`2.90 (2H,
`t, —CH2-C), 4.44 (2H,
`t. N-CH3-).
`5.94-6.81 (2H, dd, pyrrolic), 7.44-7.82 (5H. m,
`Ph); EIMS (80 eV.m/e)211(m/b).210,182. 134.
`105, 77. Anal. Calcd. for CMHBNO: C. 79.59. H.
`6.20: N, 6.63. Found: C. 79.59; H. 6.36: N. 6.52.
`
`Yield of C03
`A titration method (Niewenberg and Hegge,
`1951) was used in selected runs to determine the
`yield of the gaseous product CO2. First.
`the cul-
`ture tubes were fitted with a gas inlet-outlet de-
`vice. Sample solutions were then purged with CO3
`free (trapped by concentrated NaOH solution)
`argon gas for 10 min before irradiation. Argon gas
`was continuously passed through the reaction mix-
`ture into a CO2-free Ba(OH)2 solution. The
`trapped CO2 was then quantitated by titration of
`the Ba(OH)2 solution with standard HCl solution
`after photolysis was complete.
`
`Analytical methods
`The details of the reverse phase HPLC methods
`are described elsewhere (Gu et al.. 1987). Method
`A (used mainly for kinetic analysis) employed a
`C8 Ultrasphere (Altex) 5-it column (14.6 mm X 250
`mm) and a mobile phase of CH3CN/H20/HOAc
`(45/55/0.5). The flow rate was controlled at 1.0
`ml/min and the wavelength of detection at 314
`nm. Excellent linearities by area integration were
`obtained for ketorolac tromethamine and com-
`
`pounds 1. 3 and 4 (isolated pure materials were
`used as authentic materials) with injection sizes in
`the range of 0.015-1.0 pg. The correlation coeffi-
`cients and relative molar response factors thus
`obtained using 8 sample solutions are summarized
`
`Page 2
`
`

`
`in Table 1. Hydroperoxide 2 was unstable in mo-
`bile phase and degraded to 52% remaining after 24
`h at room temperature. Thus, the molar response
`factor for 2 (Table 1) was established using only
`two sample solutions (5.2 and 10.4 pg/ml, respec-
`tively).
`HPLC method B was used mainly for collection
`of degradation products. It employs a semi-pre-
`parative C8 Ultrasphere 5-‘u column (10 mm X 250
`mm) and a mobile phase identical to that used in
`method A.
`
`Results
`
`Material balance studies
`
`tromethamine was
`Photolysis of ketorolac
`studied in H20, H20/EtOH (9/1) and EtOH
`with laboratory black light (350 nm). Four decom-
`position products, 1-4. were isolated from HPLC
`(method B). Their structures were identified as
`shown in Scheme 1.
`
`O /
`
`O
`
`\
`
`N
`
`o
`
`..
`
`+
`
`C-0‘ NH3C(CH20H)3
`
`Ketorolac tromethamine
`
`107
`
`The material balance of the reaction as a func-
`tion of solvent and extent of reaction was de-
`
`termined using HPLC method A and the response
`factors of each degradation product shown in
`Table 1. The results are summarized in Table 2.
`
`When the photolysis was conducted in EtOH,
`94—l01% of the reacted ketorolac was accounted
`
`for regardless of the initial drug concentration, the
`extent of the reaction or the oxygen concentration.
`In deoxygenated samples, decarboxylation prod-
`uct 4 was the only observed product whereas
`under aerobic conditions, oxidation products 1-3
`accounted for ~ 30% of the degraded ketorolac
`(see Fig. la and Table 2). The relative yield of
`hydroperoxide 2 decreased with the extent of the
`reaction while the relative yields of 1 and 3 in-
`creased suggesting that 2 decomposed under the
`reaction conditions to 1 and 3.
`
`When the photolysis was conducted in H20,
`the distribution and the material balance of prod-
`ucts 1-4 were pH—dependent. At pH 2.0, where
`ketorolac exists mainly as a neutral species (free
`acid).
`the decarboxylated product, compound 4
`was the predominant product regardless of whether
`oxygen was present or not and > 80% of reacted
`ketorolac was accounted for by compounds 1-4.
`At pH 7.0 where ketorolac exists mainly as an
`anion, ondation products 1-3 became more pre-
`dominant as
`the reaction proceeded in air or
`oxygen saturated solutions. The yields of products
`1-4 at this pH decreased with the extent of the
`
`TABLE 1
`
`Linearity and molar response factors for ketorolac tromethamine
`and its degradation products at 3/ 4 nm
`
`Compound
`
`Ketorolac
`tromethamine
`
`Linearity
`correlation
`coefficient “
`
`0.9999
`
`0.9998
`—
`0.9999
`0.9999
`
`Molar
`response
`factor b
`1.00
`
`0.91
`0.98
`1.42
`1.02
`
`“ Eight concentrations and triplet injections.
`b Relative to ketorolac tromethamine.
`° Not determined due to the instability of the compound.
`
`Page 3
`
`

`
`108
`
`TABLE 2
`
`Results of laboratory black light (350 nm) photolysis of 10 pg/ ml ketorolac tromethamine solutions at various kinetic time points
`
`Solvent
`
`Atmosphere "
`
`Remaining
`
`Products distribution (96)
`
`(96)
`
`85
`10
`92
`10
`89
`13
`
`90
`11
`86
`23
`90
`55
`88
`7
`91
`
`pH 7.0 H20 °
`
`‘
`
`0.010 N 1-IC1 d
`
`Air
`
`Argon
`
`.
`
`.
`
`3
`
`4
`9
`11
`13
`—
`
`t
`
`51
`70
`41
`67
`6.5
`—
`10
`11
`t
`
`85
`85
`70
`73
`99
`98
`
`23
`8
`47
`20
`59
`100
`80
`77
`99
`
`Material
`
`balance
`(96)
`100
`101
`100
`96
`94
`95
`
`76
`46
`60
`60
`55
`48
`83
`80
`85
`
`" The desired atmosphere was purged into the photolysis media for at least 10 minutes prior to irradiation.
`b t means trace.
`° 0.025 M phosphate buffer.
`d pH = 2.05.
`
`Ketorolac
`
`Ketorolac
`
`B
`Time.min
`
`12
`
`16
`
`12
`
`15
`
`Fig. 1. HPLC chromatograms of photodegraded samples of ketorolac tromethamine in air-saturated (a) EtOH (30% remaining) and
`(b) H20 at pH 7.0 (36% remaining).
`
`Page 4
`
`

`
`reaction with as low as 46% accounted for after
`
`89% degradation in air. At pH 7.0, HPLC analysis
`of the degraded samples showed that additional
`degradation products which eluted near the solvent
`front were also found (Fig. lb). These apparently
`polar products were not identified in this study.
`It was noted that small amounts of 1 and 3
`
`were formed in argon-purged aqueous solutions at
`pH 7.0, presumably because argon purging of the
`aqueous solution did not remove all the available
`oxygen. After residual oxygen was removed by
`several freeze-thaw cycles, compound 4 was the
`only observed product in aqueous solutions.
`
`Yield of C02
`From the products isolated (Scheme 1), it was
`apparent that the decarboxylation of ketorolac is a
`major photoreaction pathway. Quantitative de-
`termination of the expected product CO2 was con-
`ducted in deaerated EtOH and H20 solutions,
`and the results are summarized in Table 3. In both
`
`solutions approximately 67% of the expected CO2
`was accounted for.
`
`Kinetics
`
`When EtOH was used as the solvent, an ap-
`parent first—order reaction was observed when the
`concentration of the trometharnine salt was s 2.0
`
`pg/ml (see Fig. 2a). However, at concentrations
`2 10 pg/ml where the photolysis solution was no
`longer optically thin (o.d. of the solution is < 0.03),
`the kinetics were non-first-order (Fig. 2b) and the
`t./,0 (time to reach 90% remaining) increased with
`increasing drug concentration. This concentration
`effect on the rate of photolysis agrees qualitatively
`with theoretical predictions (Mendenhall, 1984).
`In EtOH, oxygen appeared to quench the reac-
`
`TABLE 3
`
`C02 formation from photolysis of ketorolac tromethamine
`
`Solvent 3
`EtOH
`pH 7.0 H20 °
`
`Conc.
`1.0 mg/ml
`0.10 mg/ml
`
`% Remaining
`50
`78
`
`% of CO2 b
`67
`66
`
`“ Purged with CO2-free argon.
`b Based on the loss of ketorolac.
`° Phosphate buffer.
`
`
`
`Conc.uglmL
`
`-h0
`
`
`
`Conc.uglmL
`
`irradiation time, min.
`
`I
`16
`
`.1
`20
`
`Irradiation time, min.
`
`Fig. 2. Photolysis kinetics of ketorolac tromethamine in EtOH
`under argon (ID), air (0) or oxygen (0) atmosphere at (a) 2.0
`,u.g/ml and (b) 100 pig/ml drug concentrations.
`
`tion significantly at all concentrations studied, as
`evidenced by the decreasing rate obtained in going
`from argon to air to oxygen saturated solutions
`(Fig. 2).
`'
`The effect of oxygen concentration on the rate
`of the reaction in H20 was markedly different
`from that observed in EtOH. For example, at pH
`7.0 the initial photolysis rate in air or oxygen
`saturated solutions was similar to that in argon-
`saturated solution (see Fig. 3). However, at < 90%
`remaining, an autocatalysis reaction was observed
`in the air-saturated solutions which was not ap-
`parent in oxygen or argon-saturated solutions. The
`autocatalytic kinetic behavior was also observed in
`air-saturated aqueous solutions at pH 2.0.
`
`Page 5
`
`

`
`110
`
`Discussion
`
`Photodecarboxylation of aryl acetic acids and
`their salts has been reviewed extensively (Epling
`and Lopes, 1977; Coyle, 1978; Givens and Levi,
`1979). The primary photoprocess for the acid is
`believed to involve the singlet excited state of the
`acid which undergoes an a—bond (C—C(O)) clea-
`vage to yield an alkyl radical:
`
`Am}gcooH33(Am}nCooH)‘
`
`~ArCH;+'CO2H
`
`(1)
`
`Evidence for the radical mechanism include the
`
`detection of both alkyl and -COZH radicals from
`flash photolysis studies (Mittal et al., 1973; Meiggs
`et al., 1972) and the formation of radical coupling
`products (Epling and Lopes, 1977; Meiggs et al..
`1972)
`Although the singlet excited state of the salts
`was also believed to be involved,
`the primary
`photoreaction for the salts is less clear. Meiggs et
`al. (1972) have detected solvated electrons from
`flash photolysis of phenylacetic acid in water at
`pH 8.4 and thus indicated a radical pathway:
`
`mmxgcoo-33phcH,-+Co,+e*
`
`0)
`
`However, when sodium phenylacetate was photo-
`lyzed in the absence of oxygen in H20/(CH3),
`CDOH (99/1), 95% of the quantitative product,
`toluene, was not deuterium-incorporated. Since
`hydrogen abstraction by benzyl radical would oc-
`cur primarily at
`the C-D bond of
`the
`(CH3)2CDOH an ionic mechanism involving a
`benzyl anion followed by protonation appeared to
`be the dominating pathway (Epling and Lopes,
`1977).
`
`HK}fiCOO‘E:PhCH;—+CO2
`
`(3
`
`PhCH2"
`
`_._ _j——%>
`
`H20/(CH3)2CDOH
`(99/1)
`
`PhCH3 + PhCH2D
`95%
`
`(4)
`
`Photolysis of ketorolac tromethamine showed
`significant differences from simple aryl acetic acids
`and their salts in many ways. First,
`the benze-
`ylpyrrole structure in ketorolac has a similar con-
`jugation system to that of benzophenone which
`has a quantum yield of unity for the intersystem
`crossing (cbst)
`from singlet-excited state
`to
`triplet-excited state (Turro, 1979). The triplet en-
`ergy (ET)
`for benzophenone is 69 kcal/mol
`(Turro, 1979). If we assume that the ET for keto-
`rolac is close to 69 kcal/mol, then this energy is
`capable of breaking the C—C(O) (~ 68 kcal/mol)
`bond of ketorolac but not
`the C(O)—O (~ 106
`kcal/mol) or 0-H bond ( ~ 104 kcal/mol) (Weast,
`1972-1973) (Scheme 2).
`Thus, unlike most simple aryl acetic acids and
`salts the decarboxylation of ketorolac probably
`results from the triplet—excited state. This sugges-
`tion is supported by the experimental observation
`that
`the initial photolysis rate of ketorolac in
`EtOH and aqueous solutions was slower in the
`presence of oxygen (Fig. 2), which is an efficient
`triplet quencher (Foote, 1968).
`To test if the photolysis products of ketorolac,
`compounds 1—3 were formed from the secondary
`decomposition of the decarboxylated product 4
`(Crosby and Tang, 1969), compound 4 was sub-
`jected to the identical photolysis conditions as
`those used for ketorolac. Table 4 summarizes the
`
`results. No degradation could be found after pho-
`tolysis of 4 in EtOH for 10 min. Under identical
`conditions ketorolac tromethamine decomposed to
`25% remaining. Less than 2% degradation of 4 was
`observed after photolysis in H20 for 21 min while
`ketorolac tromethamine decomposed to 88% re-
`maining. We therefore conclude that compound 4
`is not an intermediate in the formation of the
`
`oxidation products 1-3. A mechanism which is
`consistent with all
`the experimental observations
`is outlined in Scheme 3.
`
`Page 6
`
`

`
`111
`
`ionic pathways. Oxygen has a dichotomous effect
`on the photolysis rate. Oxygen can slow down the
`reaction by quenching the triplet-excited state of
`ketorolac anion, but it can also react with alkyl
`radical
`I
`to form peroxy radical III (route b).
`When a good hydrogen donor solvent such as
`EtOH is used, peroxy radical III can abstract a
`hydrogen from EtOH to give hydroperoxide 2
`which can decompose thermally or photochem-
`ically (Lundberg 1961) to alcohol 1 and ketone 3.
`When a poor hydrogen donor solvent such as H 20
`is used peroxy radical III aggregates and eventu-
`ally initiates the free radical chain oxidation of
`ketorolac (route c). This thermal chain free radical
`oxidation is different
`from that base-catalyzed
`ionic
`autoxidation of ketorolac observed at
`
`elevated temperatures (Gu et al., 1987) and yields
`mainly 1—3 and some unidentified polar products.
`Thus, autocatalysis kinetics were observed in air-
`saturated aqueous solutions but not in EtOH.
`Quenching of triplet ketorolac by oxygen in
`oxygen-saturated aqueous solutions should be 5
`times more efficient
`than those in air—saturated
`
`solutions. Therefore,
`
`the accumulation of
`
`free
`
`TABLE 4
`
`Results of photolysis of ketorolac tromethamine and decarboxy/a-
`tion product 4 "
`
`Compound
`
`Solvent
`
`Ketorolac
`tromethamine EtOH
`EtOH
`
`4
`Ketorolac
`
`tromethamine pH 7.0 H20 b
`pH 7.0 H20 b
`
`4
`
`Photolysis Remaining ( %)
`time (min)
`
`10
`11
`
`21
`21
`
`25
`100
`
`88
`99
`
`" Substrate concentration = 100 pg/ml; ambient air.
`" Phosphate buffer.
`
`The discharge of an electron from the triplet-
`excited state of ketorolac anion followed by the
`cleavage of ot(C—C(O)) bond leads to the forma-
`tion of CO2 and alkyl radical I. In the absence of
`oxygen, the solvated electron can recombine with
`radical
`I
`to yield carbanion II (route a) which
`protonates rapidly in the presence of H20 or
`EtOH to give 4 as the major product. Thus, the
`proposed mechanism involves both radical and
`
`C
`
`Free radical oxidation
`
`/
`
`\
`
`Scheme 3
`
`I
`
`R
`
`\
`
`/
`
`N
`
`2
`
`v
`
`/\
`RN
`
`00H 3-
`
`or hi-
`
`\
`
`l
`
`R/41%/O0 HOH
`
`.
`
`go
`
`Page 7
`
`

`
`-§3
`
`MO
`
`
`
`Cone.uglmL
`
`40
`
`60
`
`Irradiation time, min.
`
`Fig. 3. Photolysis kinetics of 100 pig/ml ketorolac trometha-
`mine in H20 at pH 7.0 under argon (0) air (0) or oxygen
`(0) atmosphere.
`
`radicals in solutions is expected to be slower and
`autocatalysis was observed only with prolonged
`photolysis time (Fig. 3).
`Finally, it can be suggested that protonation of
`carboanion II is more favorable in acidic solutions
`
`(Crosby and Tang, 1969) and compound 4 re-
`mains to be the major product at pH 2 in the
`presence of oxygen (Table 2).
`
`Conclusions
`
`The pronounced effect of oxygen on the pho-
`tolysis kinetics and product distribution of l<eto—
`rolac tromethamine has led to the identification of
`
`both radical and ionic reaction pathways. The
`results presented in this study may be applied to
`other
`acidic non-steroidal
`analgesic /anti-in-
`flammatory agents containing substituted arylace-
`tic acid structure (e.g., naproxen,
`indomethacin,
`ibuprofen, ketoprofen. etc.).
`
`Acknowledgements
`
`The authors thank Mrs. J . Nelson for obtaining
`the ‘H NMR spectra, Dr. L. Partridge for obtain-
`ing the mass data and Mr. M. Chung for obtain-
`ing the CHN analysis data. Helpful discussions
`from Drs. W. Lee, and M. Powell are appreciated.
`
`References
`
`Bloomfield, S.S., Mitchell, J., Cissell, G. and Borden, T.P.,
`RS-37619 and aspirin analgesia for post-partum uterine
`cramps. Clin. Pharmacol. Ther.. 35 (1984) 228.
`Coyle, J.D., Photochemistry of carboxylic acid derivatives.
`Chem. Rev., 78 (1978) 97-123.
`Crosby, D.G. and Tang, C.-S., Photodecomposition of l-naph-
`thalene acetic acid.
`J. Agr. Food Chem.,
`17
`(1969)
`1291-1293.
`Epling, G.A. and Lopes, A., Fragmentation pathways in the
`photolysis of phenylacetic acid. J. Am. Chem. Soc, 99
`(1977) 2700-2704.
`Foote, C.S., Photosensitized oxygenations and the role of sing-
`let oxygen. Acc. Chem. Res, 1 (1968) 104-110.
`Givens. R.S. and Levi, N., The photochemistry of organic
`acids, esters. anhydrides, lactons, and imides. In S. Patai
`(Ed.), The Chemistry of Acid Derivatives, Part
`I, Wiley.
`1979. pp. 641-753.
`Granert. R. and Wollman, H., Experimental exposure of
`pharmaceutical solutions to light. Zbl. Pharm.. 117 (1978)
`993-997.
`Gu, L., Chiang, H.-S., and Becker, A. Kinetics and mecha-
`nisms of the autoxidation of ketorolac tromethamine in
`
`aqueous solution. Int. J. Pharm., 41 (1988) 95-104.
`Lachman, L.. Swartz, C1. and Cooper, J., A comprehensive
`pharmaceutical stability testing laboratory 111. A light sta-
`bility cabinet for evaluating the photosensitivity of phar-
`maceuticals. J. Am. Pharm. Assoc. 49 (1960) 213-218.
`Lin, S.-L. and Lachman. L., Photochemical considerations of
`parenteral products. Bull. Parent. Drug Assoc. 23 (1969)
`149-165.
`Lundberg. W.D., Autoxidation and Antioxidants. Vol. I. Wiley,
`1961.
`
`Ind.
`
`Meiggs, T.D. Grossweiner, L.I. and Miller, S.l., Extinction
`coefficient and recombination rate of benzyl radicals.
`l.
`Photolysis of sodium phenylacetate. J. Am. Chem. Soc, 94
`(1972) 7981-7986.
`Mendenhall, D.W., Stability of parenterals. Drug Dev.
`Pharm.. 10 (1984) 1297-1342.
`Mittal, L.J., Mittal, JP. and Hayon, E., Photo-induced de-
`carboxylation of aliphatic acids and esters in solution.
`Dependence upon state of protonation of carboxyl group.
`J. Phys. Chem, 77 (1973) 1482-1487.
`Muchowski, J.M., Unger, S.H.. Ackrell, 1., Cheung, P., Cooper.
`G.F., Cook, J., Callegra. P., Halpern. 0.. Koehler. R..
`Kluge, A.F., Van Horn, A.R., Antonio. Y., Carpio.
`1-1,.
`Franco, F., Galeazzi, E., Garcia, 1., Greenhouse. R., Guz-
`man, A., lriate, J., Leon, A., Pena, A., Perez. V.. Valdez, D.,
`Ackerman, N.. Ballaron, S.A.. Murthy, D.V.K., Rovito,
`J.R.. Tomolonis, A.J., Young, J.M., and Rooks ll. W.l-l..
`Syntheses and anti-inflammatory and analgesic activity of
`5-aryl-1,2—dihydro-3H-pyrrolo[1.2-a]pyrrole-1-carboxylic
`acids and related compounds. J. Med. Chem. 28 (1985)
`1037-1049.
`
`Niewenberg, C.J.V. and Hegge, L.A., Absorption of carbon
`dioxide by baryta in an organic solvent. Anal. Chem. Acta,
`5 (1951) 68-70.
`
`Page 8
`
`

`
`Turro, N.J., Modern Molecular Photochemistry, Benjamin, New
`York, 1979, 352 pp.
`Weast, R.C., CRC Handbook of Chemistry and Physics, 53rd
`edn. Chemical Rubber, OH 1972—1973, F189.
`Yee, J., Brown, C.R., Allison, C. and Wildman, K., Analgesia
`from intramuscular ketorolac tromethamine compared to
`
`morphine (MS) in “severe” pain following “major” surgery.
`Clin. Pharmacol. That, 37 (1985), 239.
`Yee, J., Brown, C.R., Sevelius, H. and Wild, R.N., The analgesic
`Efficacy of (1-)-5-Benzoyl-1,2-Dihydro-3H-Pyrrol[l,2a]Pyr-
`role—l-Carboxylic Acid, Tromethamine Salt
`(B)
`in Post-
`Operalive Pain. Clin. Pharmacol. Ther., 35 (1984) 285.
`
`113
`
`Page 9

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket